SCHEMBL5229993

SCHEMBL5229993

O=S(=O)(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(S(=O)(=O)c2ccccc2)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.55
TYMS P04818 1/20 0.53
MAPT P10636 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NR3C1 P04150 1/20 0.43
PGR P06401 1/20 0.43
AR P10275 1/20 0.43
ESR2 Q92731 1/20 0.43
P2RX1 P51575 1/20 0.42
PFKFB3 Q16875 1/20 0.41
FFAR4 Q5NUL3 2/20 0.41
FFAR1 O14842 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CDK7 P50613 1/20 0.41
CCNH P51946 1/20 0.41
CCNA1 P78396 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5228928 0.88 MEN1 (0.58) PPARGTYMSMAPTKMT2AMEN1
SCHEMBL5232052 0.80 TYMS (0.56) TYMSMAPTKMT2AMEN1PGR
SCHEMBL5233621 0.79 SMN1; SMN2 (0.53) MAPTKMT2AMEN1P2RX1ALDH1A1
SCHEMBL5228507 0.78 HTT (0.58) MAPTKMT2AMEN1P2RX1ALDH1A1
SCHEMBL12334559 0.77 HSD11B1 (0.64) KMT2AMEN1NR1H3
SCHEMBL12789658 0.75 PPARG (0.64) PPARGMAPTKMT2AMEN1NR3C1
SCHEMBL5230095 0.75 PRMT1 (0.52) TYMSMAPTKMT2AMEN1PGR
SCHEMBL5230563 0.75 RXFP1 (0.66) MAPTPFKFB3
SCHEMBL5229344 0.75 HDAC1 (0.51) PPARGMAPTKMT2AMEN1P2RX1
SCHEMBL8007621 0.73 TYMS (0.52) TYMSMAPTKMT2AMEN1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed